Latest News

Helius announces US FDA 510(k) submission for PoNS device label expansion...

Helius Medical Technologies has announced the filing of its US Food and Drug Administration (FDA) 510(k) submission for the Portable Neuromodulation Stimulator (PoNS) device’s...

Features

Is post-EVT intra-arterial thrombolysis a gamechanger or a risky add-on, and...

In light of a recent meta-analysis evaluating the potential benefits of administering intra-arterial thrombolysis (IAT) after an endovascular thrombectomy (EVT) procedure in large vessel...

NeuroNews’ top 10 most popular stories of August 2025

Medium-vessel occlusion (MeVO) stroke treatments continue to be a much-debated topic in the neurovascular space—a fact that is reflected in NeuroNews’ most popular stories...

Videos

Speaking to NeuroNews at the 2025 Society of NeuroInterventional Surgery (SNIS) annual meeting (14–18 July, Nashville, USA), Visish Srinivasan (Philadelphia, USA) highlights the multitude of benefits he has found since he began using the Zebra Neurovascular Access System (Q’Apel...

Most read

Features

Profiles

Wim van Zwam

Johanna Fifi

Simona Sacco